Abstract
We report on two brothers with hyperimmunoglobulinemia D (patient 1: serum immunoglobulin D [IgD] concentration initially 61 IU/ml, later on 340 IU/ml; patient 2: serum IgD concentration 144 IU/ml; normal <100 IU/ml, 97th centile) and periodic fever syndrome (HIDS). Both are compound heterozygous for the mevalonate kinase (MVK) mutations V377I and I268T. They developed significant B cell cytopenia (7%, 129/µl and 11%, 132/µl, respectively; normal ranges 12–22%, 300–500/µl) with hypogammaglobulinemia (IgG 5.48 g/l and IgG 5.22 g/l, respectively; normal range IgG 6–13 g/l). Furthermore, the clinical spectrum shows an interesting atypical autoinflammatory symptomatology. The therapy consisted of prednisone, azathioprine, and intravenous immunoglobulins (IVIG), which results in reduced incidence and severity of febrile attacks. Conclusion: The pathogenesis and clinical presentation of HIDS is still not fully understood and show a great variability. To our knowledge, severe B cell cytopenia in children with HIDS has not been reported before. Furthermore, the therapy of febrile episodes is still performed on an individual basis in affected patients.
Similar content being viewed by others
References
Ammouri W, Cuisset L, Rouaghe S, Rolland MO, Delpech M, Grateau G et al (2007) Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology (Oxford) 46:1597–1600. doi:10.1093/rheumatology/kem200
Bodar EJ, van der Hilst JC, Drenth JP, van der Meer JW, Simon A (2005) Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med 63:260–264
Cailliez M, Garaix F, Rousset-Rouvière C, Bruno D, Kone-Paut I, Sarles J et al (2006) Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. J Inherit Metab Dis 29:763. doi:10.1007/s10545-006-0408-7
Cuisset L, Drenth JP, Simon A, Vincent MF, van der Velde Visser S, van der Meer JW et al (2001) Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet 9:260–266. doi:10.1038/sj.ejhg.5200614
Danesi R, Del Tacca M (2004) Hematologic toxicity of immunosuppressive treatment. Transplant Proc 36:703–704. doi:10.1016/j.transproceed.2004.03.016
de Dios García-Díaz J, Alvarez-Blanco MJ (2001) Glucocorticoids but not NSAID abort attacks in hyper-IgD and periodic fever syndrome. J Rheumatol 28:925–926
Demirkaya E, Caglar MK, Waterham HR, Topaloglu R, Ozen S (2007) A patient with hyper-IgD syndrome responding to anti-TNF treatment. Clin Rheumatol 26:1757–1759. doi:10.1007/s10067-006-0501-1
Drenth JP, Prieur AM (1993) Occurrence of arthritis in hyperimmunoglobulinaemia D. Ann Rheum Dis 52:765–766. doi:10.1136/ard.52.10.765-b
Drenth JP, van der Meer JW (2001) Hereditary periodic fever. N Engl J Med 345:1748–1757. doi:10.1056/NEJMra010200
Drenth JP, Boom BW, Toonstra J, Van der Meer JW (1994) Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper IgD Study Group. Arch Dermatol 130:59–65. doi:10.1001/archderm.130.1.59
Drenth JP, Haagsma CJ, van der Meer JW (1994) Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) 73:133–144. doi:10.1097/00005792-199405000-00002
Drenth JP, van Deuren M, van der Ven-Jongekrijg J, Schalkwijk CG, van der Meer JW (1995) Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood 85:3586–3593
Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG et al (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 22:178–181. doi:10.1038/9696
Drenth JP, Vonk AG, Simon A, Powell R, van der Meer JW (2001) Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial. J Pharmacol Exp Ther 298:1221–1226
Frenkel J, Houten SM, Waterham HR, Wanders RJ, Rijkers GT, Duran M et al (2001) Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D. Rheumatology (Oxford) 40:579–584. doi:10.1093/rheumatology/40.5.579
Ganschow R, Lyons M, Kemper MJ, Burdelski M (2001) B-cell dysfunction and depletion using mycophenolate mofetil in a pediatric combined liver and kidney graft recipient. Pediatr Transplant 5:60–63. doi:10.1034/j.1399-3046.2001.00026.x
Haas D, Hoffmann GF (2006) Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis 1:13. doi:10.1186/1750-1172-1-13
Haraldsson A, Weemaes CM, De Boer AW, Bakkeren JA, Stoelinga GB (1992) Immunological studies in the hyper-immunoglobulin D syndrome. J Clin Immunol 12:424–428. doi:10.1007/BF00918854
Hoffmann G, Gibson KM, Brandt IK, Bader PI, Wappner RS, Sweetman L (1986) Mevalonic aciduria—an inborn error of cholesterol and nonsterol isoprene biosynthesis. N Engl J Med 314:1610–1614
Houten SM, Kuis W, Duran M, de Koning TJ, van Royen-Kerkhof A, Romeijn GJ et al (1999) Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet 22:175–177. doi:10.1038/9691
Houten SM, van Woerden CS, Wijburg FA, Wanders RJ, Waterham HR (2003) Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands. Eur J Hum Genet 11:196–200. doi:10.1038/sj.ejhg.5200933
Kuijk LM, Mandey SH, Schellens I, Waterham HR, Rijkers GT, Coffer PJ et al (2008) Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1. Mol Immunol 45:2158–2165. doi:10.1016/j.molimm.2007.12.008
Mandey SH, Kuijk LM, Frenkel J, Waterham HR (2006) A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheum 54:3690–3695. doi:10.1002/art.22194
Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I et al (2008) The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat 29:803–808. doi:10.1002/humu.20720
Naruto T (2007) MVK gene abnormality and new approach to treatment of hyper IgD syndrome and periodic fever syndrome. Nihon Rinsho Meneki Gakkai Kaishi 30:86–89. doi:10.2177/jsci.30.86
Saulsbury FT (2003) Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) in a child with normal serum IgD, but increased serum IgA concentration. J Pediatr 143:127–129. doi:10.1016/S0022-3476(03)00212-9
Simon A, Drewe E, van der Meer JW, Powell RJ, Kelley RI, Stalenhoef AF et al (2004) Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 75:476–483. doi:10.1016/j.clpt.2004.01.012
Stankovic K, Grateau G (2007) Auto inflammatory syndromes: diagnosis and treatment. Joint Bone Spine 74:544–550. doi:10.1016/j.jbspin.2007.07.005
van der Hilst JC, Drenth JP, Bodar EJ, Bijzet J, van der Meer JW, Simon A; International HIDS Study Group (2005) Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome. Amyloid 12:115–119. doi:10.1080/13506120500106982
van der Hilst JC, Simon A, Drenth JP (2005) Hereditary periodic fever and reactive amyloidosis. Clin Exp Med 5:87–98. doi:10.1007/s10238-005-0071-6
van der Meer JW, Vossen JM, Radl J, van Nieuwkoop JA, Meyer CJ, Lobatto S et al (1984) Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet 1:1087–1090. doi:10.1016/S0140-6736(84)92505-4
Acknowledgment
We thank Doctor S. Stojanov and Professor B.H. Belohradsky (University Children’s Hospital, Ludwig-Maximilian’s-University, Munich, Germany) for performing the genetic analysis in the two patients.
Conflict of interest
All authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sornsakrin, M., Wenner, K. & Ganschow, R. B cell cytopenia in two brothers with hyper-IgD and periodic fever syndrome. Eur J Pediatr 168, 825–831 (2009). https://doi.org/10.1007/s00431-008-0843-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-008-0843-6